SOURCE: Tufts Center for the Study of Drug Development

January 28, 2008 09:00 ET

Tufts Center for the Study of Drug Development to Launch R&D Senior Management Roundtable Series Feb. 28

BOSTON, MA--(Marketwire - January 28, 2008) - The Tufts Center for the Study of Drug Development today announced that it is expanding its R&D Senior Management Roundtable, from a single annual meeting to a quarterly series, and scheduled the first meeting on strategic outsourcing and global drug development for Feb. 28.

Senior biopharmaceutical and pharmaceutical executives, public policy and regulatory officials, and industry analysts are invited to participate in the quarterly series of Senior Management R&D Roundtables, hosted by Tufts CSDD.

"Our goal in creating the Roundtable series is to provide senior industry executives and policy leaders an opportunity to meet with colleagues in a neutral setting to share ideas and discuss critical R&D issues, such as project management, manufacturing, and marketing," said Tufts CSDD Director Kenneth I Kaitin.

To register, call 617-636-2170.

Roundtable meetings in 2008 will focus on the following:

--  Feb. 28 - Strategic Outsourcing and Global Drug Development
--  May 1 - Leveraging Metrics and Market Factors for Portfolio Decision
    Making
--  Sept. 11 - Optimizing Protocol Design -- Strategies to Improve Clinical
    Research Performance
--  Nov. 6 - Assessing Change and Opportunity in the Phase I Landscape

About the Tufts Center for the Study of Drug Development

The Tufts Center for the Study of Drug Development (http://csdd.tufts.edu) at Tufts University provides strategic information to help drug developers, regulators, and policy makers improve the quality and efficiency of pharmaceutical development, review, and utilization. A core element of the Center's educational efforts, the CSDD Institute for Professional Development produces the R&D Management Roundtable series, along with postgraduate level courses, training workshops, symposia, and public forums.

Contact Information

  • Contact:
    Tufts Center for the Study of Drug Development
    Charlene Neu
    617-636-2187
    Email Contact

    Business Communication Strategies
    Peter Lowy
    617-734-9980
    Email Contact